January 26, 2021
  • HOME
  • EDUCATION
  • HEALTH
  • PEOPLE
  • SCIENCE
  • TECHNOLOGY
  • HOME
  • EDUCATION
  • HEALTH
  • PEOPLE
  • SCIENCE
  • TECHNOLOGY
Dr Sys Dr Sys
top
Dr Sys
  • HOME
  • EDUCATION
  • HEALTH
  • PEOPLE
  • SCIENCE
  • TECHNOLOGY
Menu
  • HOME
  • EDUCATION
  • HEALTH
  • PEOPLE
  • SCIENCE
  • TECHNOLOGY
loading...
Latest Blogs
  • New Covid strain leaves UK isolated, with 1,500 trucks stranded at border
  • Google launches knowledge panels in search results to tackle misinformation about Covid vaccines
  • Smell training could help overcome odor distortions after COVID-19, shows study
  • Pfizer and BioNTech to request emergency authorization from FDA for Covid vaccine
  • Moderna says preliminary trial data shows its coronavirus vaccine is more than 94% effective, shares soar
  • Rural areas have fewer mental health services for young people, but great need
  • Acupuncture before surgery may reduce pain, opioid use
  • Medical myths: Mental health misconceptions
  • Exercise bloggers offer dubious advice, study suggests
  • UC Berkeley launches new center for psychedelic science and education
Home AstraZeneca
AstraZeneca trial pause is ‘not necessarily’ a setback, British health minister says

AstraZeneca trial pause is ‘not necessarily’ a setback, British health minister says

Posted By: Editorial Teamon: September 09, 2020In: HEALTH, SCIENCENo Comments

The U.K.’s health minister on Wednesday rushed to defend AstraZeneca’s decision to pause a closely-watched coronavirus vaccine trial due to safety concerns, saying that the decision is not necessarily a setback to its development. AstraZeneca announced that the pause was due to a potentially unexplained illness in one of its trials. The pharma giant’s shares […] Read more

Share 0
Tweet
Share
Share
Share

Advertising

services
solutions
vrp

2018 Powered By GroupW

  • HOME
  • EDUCATION
  • HEALTH
  • PEOPLE
  • SCIENCE
  • TECHNOLOGY